Adamis pharmaceuticals provides business update

Nda for zimhi™ submitted to the fda; phase 2/3 clinical trial preparation initiated for tempol for treatment of covid-19 nda for zimhi™ submitted to the fda; phase 2/3 clinical trial preparation initiated for tempol for treatment of covid-19
ADMP Ratings Summary
ADMP Quant Ranking